Page 140 - Read Online
P. 140
Page 10 of 15 Novotny et al. Vessel Plus 2022;6:51 https://dx.doi.org/10.20517/2574-1209.2021.139
Figure 1. Data extraction flowchart. SAVR: Surgical aortic valve replacement; TAVR: transcatheter aortic valve replacement; CABG:
coronary artery bypass graft; PCI: percutaneous coronary intervention; TAA: thoracic aortic aneurysm.
Comparing the predictors for the 30-day composite endpoint, there were important differences between
first-time and repeat AVR procedures. Although female sex, age, congestive heart failure (CHF), coronary
artery disease, cerebrovascular disease, and renal function were previously documented to impact first-time
SAVR patients’ adverse clinical outcomes [31,32] , these were not identified in the present r-AVR study.
Similarly, pulmonary hypertension, renal function, and diabetes had been found to be predictors of post-
[33]
TAVR adverse clinical outcomes in a prior study .
